| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clarification on odds ratios as conditional risk ratios
|
Tedeschi, Federico
|
|
2018
|
97 |
C |
p. 122-123
|
artikel
|
| 2 |
A mixed linear model controlling for case underascertainment across multiple cancer registries estimated time trends in survival
|
Dahm, Stefan
|
|
2018
|
97 |
C |
p. 111-121
|
artikel
|
| 3 |
Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age
|
Page, Matthew J.
|
|
2018
|
97 |
C |
p. 133-136
|
artikel
|
| 4 |
Citation analysis is also useful to assess the eligibility of biomedical research works for inclusion in living systematic reviews
|
Turki, Houcemeddine
|
|
2018
|
97 |
C |
p. 124-125
|
artikel
|
| 5 |
Citation analysis may well have a role to play in study identification, but more evaluation and system development are required
|
Thomas, James
|
|
2018
|
97 |
C |
p. 125
|
artikel
|
| 6 |
Cochrane Qualitative and Implementation Methods Group guidance series—paper 1: introduction
|
Noyes, Jane
|
|
2018
|
97 |
C |
p. 35-38
|
artikel
|
| 7 |
Cochrane Qualitative and Implementation Methods Group guidance series—paper 4: methods for assessing evidence on intervention implementation
|
Cargo, Margaret
|
|
2018
|
97 |
C |
p. 59-69
|
artikel
|
| 8 |
Cochrane Qualitative and Implementation Methods Group guidance series—paper 3: methods for assessing methodological limitations, data extraction and synthesis, and confidence in synthesized qualitative findings
|
Noyes, Jane
|
|
2018
|
97 |
C |
p. 49-58
|
artikel
|
| 9 |
Cochrane Qualitative and Implementation Methods Group guidance series—paper 5: methods for integrating qualitative and implementation evidence within intervention effectiveness reviews
|
Harden, Angela
|
|
2018
|
97 |
C |
p. 70-78
|
artikel
|
| 10 |
Cochrane Qualitative and Implementation Methods Group guidance series—paper 2: methods for question formulation, searching, and protocol development for qualitative evidence synthesis
|
Harris, Janet L.
|
|
2018
|
97 |
C |
p. 39-48
|
artikel
|
| 11 |
Cochrane Qualitative and Implementation Methods Group guidance series—paper 6: reporting guidelines for qualitative, implementation, and process evaluation evidence syntheses
|
Flemming, Kate
|
|
2018
|
97 |
C |
p. 79-85
|
artikel
|
| 12 |
Cochrane systematic reviews of interventions for risk factors correlate weakly with global risk factor burden: a cross-sectional study
|
Roberts, David J.
|
|
2018
|
97 |
C |
p. 103-110
|
artikel
|
| 13 |
Editorial Board
|
|
|
2018
|
97 |
C |
p. IFC
|
artikel
|
| 14 |
Explaining odds ratios as conditional risk ratios
|
Hoppe, Fred M.
|
|
2018
|
97 |
C |
p. 123-124
|
artikel
|
| 15 |
Many randomized clinical trials may not be justified: a cross-sectional analysis of the ethics and science of randomized clinical trials
|
De Meulemeester, Julie
|
|
2018
|
97 |
C |
p. 20-25
|
artikel
|
| 16 |
Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism
|
Riva, Nicoletta
|
|
2018
|
97 |
C |
p. 1-13
|
artikel
|
| 17 |
Node-making process in network meta-analysis of nonpharmacological treatment are poorly reported
|
James, Arthur
|
|
2018
|
97 |
C |
p. 95-102
|
artikel
|
| 18 |
No difference in knowledge obtained from infographic or plain language summary of a Cochrane systematic review: three randomized controlled trials
|
Buljan, Ivan
|
|
2018
|
97 |
C |
p. 86-94
|
artikel
|
| 19 |
Recommendations for assessing the risk of bias in systematic reviews of health-care interventions
|
Viswanathan, Meera
|
|
2018
|
97 |
C |
p. 26-34
|
artikel
|
| 20 |
Re-randomization increased recruitment and provided similar treatment estimates as parallel designs in trials of febrile neutropenia
|
Kahan, Brennan C.
|
|
2018
|
97 |
C |
p. 14-19
|
artikel
|
| 21 |
Systematic Review Qualitative Methods Series reflect the increasing maturity in qualitative methods
|
Tugwell, Peter
|
|
2018
|
97 |
C |
p. vii-viii
|
artikel
|
| 22 |
Table of Contents
|
|
|
2018
|
97 |
C |
p. iii-v
|
artikel
|
| 23 |
Why the ethical justification of randomized clinical trials is a scientific question
|
Shamy, Michel
|
|
2018
|
97 |
C |
p. 126-132
|
artikel
|
Tijdschrift beschrijving